IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis

Date
2018
Author
Zeft, Andrew S.
Arthur, Victoria L.
Shuldiner, Emily
Remmers, Elaine F.
Hinks, Anne
Grom, Alexei A.
Martini, Alberto
Gattorno, Marco
ÖZEN, SEZA
Prahalad, Sampath
Bohnsack, John F.
Ilowite, Norman T.
Mellins, Elizabeth D.
Russo, Ricardo
Len, Claudio
Oliveira, Sheila
Yeung, Rae S. M.
Rosenberg, Alan M.
Wedderburn, Lucy R.
Anton, Jordi
Haas, Johannes-Peter
Roesen-Wolff, Angela
Minden, Kirsten
Szymanski, Ann Marie
Thomson, Wendy
Kastner, Daniel L.
Woo, Patricia
Ombrello, Michael J.
Foell, Dirk
Metadata
Show full item record
Abstract
Objective. To determine whether systemic juvenile idiopathic arthritis (JIA) susceptibility loci that were identified by candidate gene studies demonstrate association with systemic JIA in the largest study population assembled to date.
URI
http://hdl.handle.net/20.500.12627/177484
https://doi.org/10.1002/art.40498
Collections